Join us at an upcoming event
Connect with the hemophilia community
CelebrVIII with ALTUVIIIO
Join us for a celebration!
- Hear from and talk to Peer speakers about their experiences with ALTUVIIIO
- Participate in an activity
- Meet others in the community
- and more!
Reach out to your local CoRe to learn how you can attend a CelebrVIII event.
Hemophilia Federation of American (HFA) Annual Symposium
- March 27-30, 2025
- Sheraton San Diego Hotel & Marina | San Diego, CA
- Booth #313
ALTUVIIIO Symposium Dinner: CelebrVIII
- Join us for a celebration! A Community Relations and Education (CoRe) Manager will talk about the benefits and safety of ALTUVIIIO®. Throughout the program, you’ll get to participate in an activity and hear from Peer speakers about their firsthand experiences with this treatment, and what making the switch has meant for them
- Friday, March 27, 2025
- 7:00 PM–8:30 PM
Texas Bleeding Disorders Conference (TBDC)
- June 20-22, 2025
- Dallas/Plano Marriott at Legacy Town Center | Plano, Texas
Pennsylvania Bleeding Disorders Conference
- May 16-18, 2025
- Hershey Lodge | Hershey, Pennsylvania
This event is open to members of the Western or Eastern PA Bleeding Disorders Foundations or patients of one of the seven HTCs in PA. Registration is limited to immediate family members living in the household with the person who has a bleeding disorder. To request a registration form, send an email to rsvp@wpbdf.org or call 724-741-6160. Once approved, you will receive a link to fill out your registration form online.
National Bleeding Disorders Foundation’s (NBDF) Bleeding Disorders Conference (BDC)
- August 21-23, 2025
- Gaylord Rockies Resort & Convention Center | Aurora, CO
Unless otherwise noted, Sanofi, the host of this industry-sponsored educational symposium/networking event, is solely responsible for its content, including any information presented or distributed during the event. The National Bleeding Disorders Foundation does not endorse any particular treatment products or manufacturers; any reference to a product name is not an endorsement by NBDF. NBDF is not a regulatory agency and cannot make recommendations relating to the safety of manufacturing of specific treatment products. For recommendations of a particular product, the regulatory authority in a particular country must make these judgments based on domestic legislation and national health policies.
